[HTML][HTML] Prognostic and predictive gene signature for adjuvant chemotherapy in resected non–small-cell lung cancer
CQ Zhu, K Ding, D Strumpf, BA Weir… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
Journal of clinical oncology, 2010•ncbi.nlm.nih.gov
Prognostic and Predictive Gene Signature for Adjuvant Chemotherapy in Resected Non–Small-Cell
Lung Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2988634
Other Formats PubReader PDF (285K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Lung Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2988634
Other Formats PubReader PDF (285K) Actions Cite Collections Share Permalink Copy
RESOURCES Similar articles Cited by other articles Links to NCBI Databases Journal List J …
Abstract
Purpose
The JBR. 10 trial demonstrated benefit from adjuvant cisplatin/vinorelbine (ACT) in early-stage non–small-cell lung cancer (NSCLC). We hypothesized that expression profiling may identify stage-independent subgroups who might benefit from ACT.
ncbi.nlm.nih.gov